tech-scienceKXNEWDRUGAPPNTLAOpen

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?

kalshiView on kalshiAdded Apr 17, 2026

YesBuy Yes

39¢

39% implied probability

NoBuy No

61¢

61% implied probability

Volume$416

Liquidity—

Open Interest$218

ExpiresSep 1, 2026

Yes Price$0.39

No Price$0.61

ResolvedPending

OutcomePending

Probability Distribution

Yes 39%

61% No

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes.

ID7766

Platformkalshi

Categorytech-science

SubcategoryKXNEWDRUGAPPNTLA

StatusOpen

CreatedApr 17, 2026

ExpiresSep 1, 2026

Resolved—